Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bagby

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Endocrine-Related Cancer|January 27, 2018
Development of new preclinical models to advance adrenocortical carcinoma researchKatja Kiseljak-Vassiliades, Yu Zhang, Stacey M Bagby, et al.
Plos One|April 10, 2024
Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL)Hayley J Hawkins, Betelehem W Yacob, Monica E Brown, et al.
Journal for Immunotherapy of Cancer|February 10, 2019
Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenograftsA Capasso, J Lang, T M Pitts, et al.
Frontiers in Pharmacology|July 3, 2015
Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer modelsS Lindsey Davis, Kelli M Robertson, Todd M Pitts, et al.
Molecular Cancer Therapeutics|July 21, 2018
Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling MechanismsAaron J Scott, John J Arcaroli, Stacey M Bagby, et al.
Frontiers in Oncology|April 16, 2026
Efficacy of an XPO1 inhibitor in combination with irinotecan in a preclinical colorectal cancer modelRobert W Lentz, Adrian T A Dominguez, Nicole Baranda Balmaceda, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Decitabine reverses innate immune gene suppression in rare melanomasMorgan L MacBeth, Stacey M Bagby, Jessica S W Borgers, et al.
Molecular Cancer Therapeutics|July 13, 2026
Decitabine reverses innate immune gene suppression in rare melanomasMorgan L MacBeth, Stacey M Bagby, Jessica S W Borgers, et al.
Oncotarget|July 8, 2016
Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancerTodd M Pitts, Erica L Bradshaw-Pierce, Stacey M Bagby, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2019
Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor MicroenvironmentJulie Lang, Anna Capasso, Kimberly R Jordan, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Endocrine-Related Cancer|January 27, 2018
Development of new preclinical models to advance adrenocortical carcinoma researchKatja Kiseljak-Vassiliades, Yu Zhang, Stacey M Bagby, et al.
Plos One|April 10, 2024
Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL)Hayley J Hawkins, Betelehem W Yacob, Monica E Brown, et al.
Journal for Immunotherapy of Cancer|February 10, 2019
Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenograftsA Capasso, J Lang, T M Pitts, et al.
Frontiers in Pharmacology|July 3, 2015
Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer modelsS Lindsey Davis, Kelli M Robertson, Todd M Pitts, et al.
Molecular Cancer Therapeutics|July 21, 2018
Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling MechanismsAaron J Scott, John J Arcaroli, Stacey M Bagby, et al.
Frontiers in Oncology|April 16, 2026
Efficacy of an XPO1 inhibitor in combination with irinotecan in a preclinical colorectal cancer modelRobert W Lentz, Adrian T A Dominguez, Nicole Baranda Balmaceda, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Decitabine reverses innate immune gene suppression in rare melanomasMorgan L MacBeth, Stacey M Bagby, Jessica S W Borgers, et al.
Molecular Cancer Therapeutics|July 13, 2026
Decitabine reverses innate immune gene suppression in rare melanomasMorgan L MacBeth, Stacey M Bagby, Jessica S W Borgers, et al.
Oncotarget|July 8, 2016
Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancerTodd M Pitts, Erica L Bradshaw-Pierce, Stacey M Bagby, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2019
Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor MicroenvironmentJulie Lang, Anna Capasso, Kimberly R Jordan, et al.
Pageof 14